Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102391169B offers high-purity BPH intermediate synthesis. Ether solvent method ensures safety and scalability for pharmaceutical supply chains.
Patent CN111646917A details a metal-free route to N-(4-iodophenyl) amides using m-CPBA and HFIP, offering cost reduction and high purity for pharmaceutical intermediates.
Patent CN112979545B reveals a metal-free route to 5-selenoquinolines using PIFA. This method offers high regioselectivity and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN105949079A enables green synthesis of pharmaceutical intermediates. Visible light catalysis ensures high purity and supply chain reliability for global buyers.
Patent CN111303073A details a green route for Fenthiolamide using benzothiazolone, offering cost reduction and high purity for herbicide manufacturing.
Patent CN113563305B reveals a cost-effective, high-yield route for 2-(4-phenoxyphenyl)-6-(N-substituted oxycarbonyl piperidine-4-) nicotinamide, ensuring reliable supply chain stability.
Patent CN105693621A details a novel oxidative sulfonylation method using stable sulfinate salts, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN111187219B reveals stable photocatalytic salt enabling cost reduction in pharmaceutical intermediates manufacturing and high-purity supply chain reliability.
Novel crystalline cephamycin intermediate via salt formation. Enhances stability and purity for cefminox sodium production. Reliable supply chain solution.
Patent CN115745822A enables green visible light synthesis of N-formyl amides using copper catalysis, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel synthesis method for NR chloride using TMSOTf activation. Reduces cost and improves purity for pharmaceutical intermediates manufacturing.
Patent CN107739322B details a novel Ir-catalyzed C-H activation route for sulfonamides. Discover cost-effective, high-yield manufacturing solutions for pharma and agrochemical intermediates.
Advanced synthesis of Boceprevir intermediate via patent CN103387510B. Offers cost reduction in pharmaceutical manufacturing and reliable supply chain solutions.
Patent CN112961116B reveals a green ultrasound-assisted method for synthesizing high-purity benzoxazole intermediates using recyclable deep eutectic solvents.
Patent CN102356063B details a safe synthesis route for quinoline intermediates. This method avoids hazardous azides ensuring high purity and supply chain reliability for pharmaceutical production.
Patent CN102115486B reveals a two-step Aramchol synthesis route reducing costs and improving supply chain reliability for global pharmaceutical intermediates manufacturers.
Novel chloroacetamide-based method reduces side reactions and costs for PDE5 inhibitor intermediates, offering scalable supply chain solutions.
Patent CN102898342A details a novel chiral hydroxyl amide synthesis offering 99% conversion in catalysis. Discover cost-effective manufacturing and supply advantages.
Patent CN112142656B reveals a green biomass-copper catalyzed route for sulfonyl pyridine amides, offering cost-effective manufacturing and scalable pharmaceutical intermediate production.
Patent CN112047925B details a copper-catalyzed oxidative amination route for N-(aryl/heteroaryl) alkyl-diamides, offering significant cost reduction in API manufacturing and scalable supply chain solutions.